...BRCA1 PVs, 433 carried BRCA2 PVs, and 10,495 were non-carriers. After a median follow-up of 8.4 years, 10.9% of BRCA1 ca...
...BRCA1, and p53 and normalized cell cycle regulation by modulating the expression of CDK4, Cyclin D1/E, and p21/p27. Cell...
...BRCA1 and BRCA2 (hereafter referred to as BRCA1/2) hereditary breast and ovarian cancer genes three decades ago, genetic...
...BRCA1-associated tumor progression is involved.
...BRCA1, CD36, ENO3, INHBB, PHLDA2) model showed robust predictive efficacy (1-, 3-, 5-year OS area under the curve: 0.889...
...BRCA1-deficient breast cancers. However, the reason why LPs are prone to transform with BRCA1 deficiency has not been el...
...BRCA1 mutation carriers are at increased risk of developing early-onset disease. While bariatric surgery reduces the inc...
Germline loss-of-function variants in BRCA1 and BRCA2 are established drivers of hereditary breast and ovarian cancer, o...
...BRCA1, BRCA2, and PALB2 resulted in a risk distribution that was essentially disjoint from the non-carriers, regardless ...
...BRCA1-associated protein 1 (BAP1) tumor suppressor gene. This alteration typically occurs as an early clonal event in me...
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269